A carregar...
Novel doses of sacubitril/valsartan in patients unable to tolerate traditional therapy: Effects on N‐terminal pro B‐type natriuretic peptide levels
BACKGROUND: Widespread use of angiotensin receptor blocker and neprilysin inhibitor (ARNI) remains low, and many patients are unable to tolerate the medication due to hypotension at the currently recommended starting dose. HYPOTHESIS: The aim of this study is to assess if lower than standard doses o...
Na minha lista:
| Publicado no: | Clin Cardiol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley Periodicals, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7803354/ https://ncbi.nlm.nih.gov/pubmed/33277928 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.23509 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|